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Radical Surgery in the Treatment of Localized Carcinoma 
of the Prostate 
Dinesh J. Telang, MD,* Brian J. Miles, MD,^  Riad N. Farah, MD,* Ray H. Littleton, MD,* 
Aaron K. Kirkemo, MD,* James O. Peabody, MD,* David A. Burks, MD,* Caleb Fleming, 
MD,* and Joseph C. Cerny, MD* 
New methods of early detection combined with recent advances in surgical techniques have resulted 
in more patients undergoing radical surgery for treatment of localized carcinoma of the prostate. 
Over 350 radical prostatectomies have heen performed hy our group since January 1987. We review 
the role of radical prostatectomy in the treatment of prostate cancer and our experience with 100 
patients undergoing radical retropubic prostatectomy since the advent of nerve-sparing techniques to 
preserve potency. (Henry Ford Hosp Med J 1992:40:108-10) 
T he first reported operation for prostate cancer was a partial perineal prostatectomy for tumor performed by Theodor 
Billroth in 1867. Leisrink undertook the first reported total per-
ineal prostatectomy in 1883; unfortunately, the patient died of 
"exhaustion" in the eariy postoperative period. In 1904 Hugh 
Hampton Young, with the help of Halstead, planned and per-
formed the first radical perineal prostatectomy. Young reviewed 
four cases in 1905 and noted that a small nodule may be an early 
sign of carcinoma of the prostate. He advised open biopsy and, if 
positive, subsequent perineal radical prostatectomy. Mi lien ad-
vocated the retropubic approach to radical prostatectomy in 
1947, stating that exposure to the gland was superior (1). 
Five-year survival after radical prostatectomy for prostate 
cancer was 50% until 1941 when the discovery that prostate car-
cinoma was androgen-dependent coincided with the advent of 
hormonal therapy, Cleariy the lack both of accurate staging and 
of diagnosis until tumors became symptomatic resulted in diag-
nosis of the disease at an advanced (or at least locally advanced) 
stage. This may explain the poor survival statistics and in part 
the lack of enthusiasm for radical surgery for prostate cancer un-
til the last decade. 
As a resutt of the recent developments in early diagnosis, par-
ticulariy prostate-specific antigen (PSA) and transrectal ultra-
sonography (TRUS), we are diagnosing more cases of prostate 
cancer, of which a significant proportion are clinically confined 
to the prostate. Whether the use of screening PSA and TRUS 
will ultimately result in earlier diagnosis and decreased mortal-
ity from carcinoma of the prostate, as screening mammography 
has done for breast cancer, is yet unknown. Recent advances in 
surgical techniques have diminished blood loss, limited inconti-
nence and allowed sparing of the cavernous nerves responsible 
for erection. Consequently, the number of radical retropubic 
prostatectomies performed at our institution has increased from 
less than 25 per year in the 1970s to more than 350 since January 
1987. 
We reviewed our experience with the nerve-sparing prosta-
tectomy in an attempt to answer the following questions; Does 
sparing of the neurovascular bundle (NVB) contribute to posi-
tive surgical margins? Should the NVBs be resected routinely in 
patients with poorly differentiated tumors? Are we effective at 
preserving potency, and do we have an acceptably low inci-
dence of urinary incontinence and other complications? 
Methods 
We reviewed the records of the first 100 Henry Ford Hospital 
patients who underwent nerve-sparing radical prostatectomy 
done by a single staff urologist (BJM) and assessed margin 
status, tumor grade, potency, continence, and complications. 
Patients ranged in age from 52 to 74 years (mean 66 years). 
Nerve-sparing prostatectomy was planned in all patients; crite-
ria for resecting the NVB included preoperative impotence or 
clinical suspicion of involvement of the NVB. The NVBs were 
not routinely resected in patients with poorly differentiated car-
cinoma. 
Clinical staging was based on digital rectal examination, 
bone scan, and computed tomography of the pelvis. All patients 
had normal levels of prostatic acid phosphatase. 
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Specimens were graded as well, moderately, or poorly differ-
entiated conesponding to Gleason scores of 2 to 4,5 to 7, and 8 
to to, respectively. Specimens were evaluated for margin status 
and location of tumor, specifically whether margins were clear 
and whether there was capsular involvement, extracapsular dis-
ease, and seminal vesicle or lymph node involvement. 
Results 
Ofthe too patients, 52 had organ-confined disease. Margins 
were clear in 70 patients. Of the 70, 16 had capsular penetration 
without transgressing the capsule; two of these had periprostatic 
extension of tumor yet had surgically clear margins. A total of 
27 patients had histologic evidence of locally advanced carci-
noma with positive surgical margins; 12 of these patients had 
seminal vesicle invasion. Three patients had microscopic stage 
Dl disease found on permanent section of pelvic lymph nodes 
despite negative frozen sections at the time of surgery. Atl three 
of these patients had positive surgical margins; two had exten-
sive seminal vesicle invasion. 
Patients with poorly differentiated cancers were more likely 
to have positive margins. Of all tumors, 14% were poorly differ-
entiated. A total of 38% of the patients with pooriy differenti-
ated cancer had positive margins whereas 26% of those with 
well or moderately differentiated tumors (Gleason score 2 to 7) 
had positive margins. 
Fourteen patients had one or both NVBs resected because of 
clinically suspicious margins. Ten of these patients had positive 
margins. None appeared to benefit pathologically from wide ex-
cision of the NVB. Most patients with positive margins had ex-
tracapsular tumor at multiple sites, making the NVB status inel-
evant. Two patients had positive margins laterally (where the 
NVB was spared) as the single point of margin positivity. These 
patients may have benefited from wide resection of the NVB on 
the involved side. Follow-up is too short at this time (mean 2 
years) to adequately address progression or survival in our se-
ries. 
A total of 66 patients were potent preoperatively. Of these, 61 
had at least one NVB left intact at surgery. A totat of 35 (57%) of 
these patients regained potency. This compares favorably with 
the overall potency rates of 63% and 72% reported by Catalona 
and Bigg (2) and Walsh (3), respectivety. Walsh et al (4) re-
ported recovery of potency in 69% of patients after unilateral 
nerve-sparing procedures. Catalona (5) reported a 39% inci-
dence of preservation of potency after unilateral sacrifice of an 
NVB. Our own experience is not as encouraging; only one of 
nine patients who had a single NVB left intact regained erectile 
function. 
Margin status did seem to conelate with preservation of erec-
tile function. Patients with surgically clear margins had an ex-
cellent rate of recovery of potency, with 64% regaining erectile 
function. Those with surgically positive margins did not fare as 
welt; only 8 (42%) of 19 remained potent. Several hypotheses 
may be considered; Is there neuropraxia from the procedure 
along with impaired healing in the face of local persistence of 
disease? Is there local invasion of the NVB by carcinoma? Do 
patients who undergo adjuvant radiation therapy sustain addi-
tional damage to the NVB? Are there psychological confound-
ing factors associated with incompletely resected cancer, lack of 
libido, etc.? 
Complications 
Incontinence was uncommon in the patients studied. Only 
4% had moderate-to-severe incontinence (two or more pads per 
day), with another 5% experiencing minimal stress incontinence 
with strenuous exercise or activity. Incontinence was indepen-
dent of margin status in our series. 
Other complications were uncommon as well. Bladder neck 
contractures have occuned in five patients; four have resolved 
with a simple dilatation or transurethral resection. The fifth pa-
tient has a recalcitrant vesical neck contracture despite three re-
sections and multiple dilatations. 
Deep venous thrombosis occuned in two patients despite uni-
versal use of sequential compression devices; one patient subse-
quently developed a pulmonary embolus and required place-
ment of a Greenfield filter. One patient had a wound infection 
followed by dehiscence. One patient died at home of unknown 
causes three weeks postoperatively. 
Discussion 
Since the anatomic approach to radical retropubic prostatec-
tomy was described by Walsh et at (6), there has been consider-
able debate about whether the sparing of the NVB limits the 
effectiveness of the operation to attain the primary objective; 
complete extirpation of localized carcinoma of the prostate. The 
secondary objective is to preserve potency, ideally with minimal 
morbidity and mortality. 
Advantages realized by the technique of Walsh (7) include a 
more anatomic dissection resulting in improved rates of potency 
and continence as well as decreased blood loss with improved 
control of the dorsal vein complex. Potential disadvantages in-
clude concems about compromising the cancer control aspects 
ofthe operation with increased risk of having positive margins. 
In 1987 Walsh (3) reviewed pathological differences between 
the radical perineal prostatectomy, the standard radical retro-
pubic prostatectomy, and the nerve-sparing radical retropubic 
prostatectomy, Walsh found at that time that the standard ap-
proaches did not routinely or reliably excise the NVB, that more 
periprostatic tissue could be resected retropubically, and that 
identification of the NVB allowed a wider anatomic resection of 
the periprostatic tissue when clinically indicated. 
Catalona and Bigg (2) reviewed 250 patients who underwent 
nerve-sparing radical retropubic prostatectomy and concluded 
that sparing the NVBs did not compromise the adequacy of tu-
mor excision in the majority of patients. While patients with 
larger or poorly differentiated tumors may be at higher risk for 
leaving a positive margin by sparing an NVB, there was no evi-
dence that wide excision of an NVB was of any benefit. Patients 
with large or poorly differentiated tumors were unlikely to be 
cured with any form of radical prostatectomy, as 78% of poorly 
differentiated tumors had capsular penetration, positive surgical 
margins, or both. 
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In a pathologic study of radical prostatectomy specimens, 
Villers et al (8) concluded that 50% of prostate cancers escape 
the prostate along the perineural spaces. Based on observations 
that 48% of positive margins in theoretically curable cases occur 
at the apex, Stamey and colleagues (9) stated that high-positive 
margin rates could be improved by careful apical dissection and 
wide bilateral resection of the NVBs in all patients with apical 
tumors regardless of the side of the nodule. 
In summary, the nerve-sparing radical retropubic prostatec-
tomy is an excellent anatomic procedure for prostate cancer in 
selected patients. In our series, 70% of 100 patients had patho-
logically clear margins. This is comparable to the 57% to 77% 
reported in series by Catalona and Bigg (2) and Stamey et al (9). 
Margin status was compromised histologically in two of 100 pa-
tients by sparing an NVB; the remainder of the patients with 
positive margins had multiple sites or large areas which were 
unclear. While there was a higher positive margin rate with 
poorly differentiated tumors (38% versus 26% in well or moder-
ately differentiated cancer), we believe that this reflects the limi-
tations of radical prostatectomy in the treatment of localized car-
cinoma of the prostate. Only two of 30 patients with positive 
margins in our series may have benefited from wide resection of 
the NVB; neither patient has evidence of recunence to date. No 
clear-cut evidence exists in our experience to indicate that wide 
resection of the NVBs would be of any benefit. Finally, the mor-
bidity and mortality of the nerve-sparing prostatectomy are ac-
ceptably low with good expectations of preservation of potency. 
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